Stuart G Jarrett Selected Research

Melanoma (Melanoma, Malignant)

1/2019	cAMP-mediated regulation of melanocyte genomic instability: A melanoma-preventive strategy.
1/2017	Divergence of cAMP signalling pathways mediating augmented nucleotide excision repair and pigment induction in melanocytes.
12/2016	AKAP12 mediates PKA-induced phosphorylation of ATR to enhance nucleotide excision repair.
12/2015	Defining the Contribution of MC1R Physiological Ligands to ATR Phosphorylation at Ser435, a Predictor of DNA Repair in Melanocytes.
2/2015	Dual functions of NME1 in suppression of cell motility and enhancement of genomic stability in melanoma.
6/2014	PKA-mediated phosphorylation of ATR promotes recruitment of XPA to UV-induced DNA damage.
1/2013	NM23 deficiency promotes metastasis in a UV radiation-induced mouse model of human melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stuart G Jarrett Research Topics

Disease

7	Melanoma (Melanoma, Malignant) 01/2019 - 01/2013
4	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2018 - 06/2014
4	Genomic Instability 12/2018 - 01/2009
3	Xeroderma Pigmentosum (Kaposi's Disease) 12/2018 - 06/2014
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2013 - 11/2008
3	Macular Degeneration (Age-Related Maculopathy) 01/2013 - 11/2008
2	Glaucoma 01/2013 - 11/2008
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2013 - 11/2008
2	Neoplasm Metastasis (Metastasis) 09/2009 - 01/2009
1	DNA Repair-Deficiency Disorders (Chromosome Instability Syndromes) 12/2015
1	Vision Disorders (Hemeralopia) 08/2012
1	Status Epilepticus (Complex Partial Status Epilepticus) 11/2008
1	Retinal Degeneration 11/2008
1	Ketosis 08/2008
1	Drug Resistant Epilepsy 08/2008
1	Temporal Lobe Epilepsy 04/2008
1	Epilepsy (Aura) 04/2008
1	Seizures (Absence Seizure) 04/2008
1	Carcinogenesis 06/2005

Drug/Important Bio-Agent (IBA)

6	Type 1 Melanocortin ReceptorIBA 01/2019 - 06/2014
5	Proteins (Proteins, Gene)FDA Link 12/2018 - 06/2014
3	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2017 - 12/2015
3	Mitochondrial DNA (mtDNA)IBA 01/2013 - 04/2008
3	Retinaldehyde (Retinal)IBA 01/2013 - 11/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 06/2005
2	Exonucleases (3' 5' Exonuclease)IBA 09/2009 - 01/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2008 - 06/2005
1	Cisplatin (Platino)FDA LinkGeneric 01/2017
1	Protein Kinases (Protein Kinase)IBA 01/2017
1	Melanins (Melanin)IBA 01/2017
1	PlatinumIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 12/2015
1	Fibronectins (Fibronectin)IBA 02/2015
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2013
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 01/2013
1	Histidine KinaseIBA 01/2009
1	Etoposide (VP 16)FDA LinkGeneric 01/2009
1	Phosphotransferases (Kinase)IBA 01/2009
1	Nucleoside-Diphosphate KinaseIBA 01/2009
1	IronIBA 11/2008
1	Chelating AgentsIBA 11/2008
1	AntioxidantsIBA 11/2008
1	3-Hydroxybutyric Acid (beta-Hydroxybutyric Acid)IBA 08/2008
1	Kainic Acid (Kainate)IBA 04/2008

Therapy/Procedure

1	Therapeutics 08/2008
1	Carbohydrate-Restricted Diet (Low Carbohydrate Diet) 08/2008
1	Ketogenic Diet 08/2008